Showing results (1811-1820 of 2,011) with videos related to

Sort By:
Pageof 202
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2015
IL-17A-Producing γδ T Cells Suppress Early Control of Parasite Growth by Monocytes in the LiverMeru Sheel, Lynette Beattie, Teija C M Frame, et al.
Geroscience|February 6, 2026
PTUPB improves cognitive function in Alzheimer's disease associated with enhancing cerebral vascular myogenic response and attenuating vascular remodelingGilbert C Morgan, Andrew Gregory, Chengyun Tang, et al.
Nature Communications|January 13, 2026
Intelectin-2 is a broad-spectrum antimicrobial lectinAmanda E Dugan, Deepsing Syangtan, Eric B Nonnecke, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Dual Inhibition of sEH and COX-2 Improved Cognition in Alzheimer's Disease via Enhanced Myogenic Response and Cerebral Artery DistensibilityGilbert C Morgan, Andrew Gregory, Chengyun Tang, et al.
Cell Reports|October 6, 2016
Type I Interferons Regulate Immune Responses in Humans with Blood-Stage Plasmodium falciparum InfectionMarcela Montes de Oca, Rajiv Kumar, Fabian de Labastida Rivera, et al.
Translational Behavioral Medicine|January 25, 2023
Factors influencing the implementation of the EuroFIT lifestyle change program in professional football clubs in Europe: a qualitative study in four European countriesFemke van Nassau, Anita Huis, Irene van de Glind, et al.
JAMA Network Open|October 20, 2020
Changes in Cigarette Consumption With Reduced Nicotine Content Cigarettes Among Smokers With Psychiatric Conditions or Socioeconomic Disadvantage: 3 Randomized Clinical TrialsStephen T Higgins, Jennifer W Tidey, Stacey C Sigmon, et al.
The Journal of Clinical Investigation|October 2, 2023
STING activation promotes autologous type I interferon-dependent development of type 1 regulatory T cells during malariaYulin Wang, Fabian De Labastida Rivera, Chelsea L Edwards, et al.
The Journal of Clinical Investigation|May 3, 2014
Type I IFN signaling in CD8- DCs impairs Th1-dependent malaria immunityAshraful Haque, Shannon E Best, Marcela Montes de Oca, et al.
Blood Advances|September 10, 2021
Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final dataSteven M Horwitz, Julia J Scarisbrick, Reinhard Dummer, et al.
Pageof 202